CNS Pharmaceuticals Inc is a biotechnology company focused on developing innovative therapies for the treatment of central nervous system (CNS) cancers
The company specializes in formulating and advancing drug candidates that target various forms of brain tumors, aiming to improve treatment options and outcomes for patients faced with challenging diagnoses. Through its research and development efforts, CNS Pharmaceuticals strives to address significant unmet medical needs in the oncology sector, leveraging scientific expertise and novel approaches to bring potential new therapies to market.
Shares of NIO Inc. (NYSENIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has resigned as the Chief Financial Officer for personal and family
